Semi-quantitative models for identifying potent and selective transthyretin amyloidogenesis inhibitors.

about

Semi-quantitative models for identifying potent and selective transthyretin amyloidogenesis inhibitors.

Item

http://www.wikidata.org/entity/Q38720600

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年論文

@yue

2017年論文

@zh-hant

2017年論文

@zh-hk

2017年論文

@zh-mo

2017年論文

@zh-tw

2017年论文

@wuu

2017年论文

@zh

2017年论文

@zh-cn

name

Semi-quantitative models for i ...... in amyloidogenesis inhibitors.

@en

type

Item

label

Semi-quantitative models for i ...... in amyloidogenesis inhibitors.

@en

prefLabel

Semi-quantitative models for i ...... in amyloidogenesis inhibitors.

@en

P1476

Semi-quantitative models for i ...... in amyloidogenesis inhibitors.

@en

P2093

David E Mortenson

http://www.w3.org/2001/XMLSchema#string

Evan T Powers

http://www.w3.org/2001/XMLSchema#string

Stephen Connelly

http://www.w3.org/2001/XMLSchema#string

Steven M Johnson

http://www.w3.org/2001/XMLSchema#string

Sungwook Choi

http://www.w3.org/2001/XMLSchema#string

P2860

Fibril in senile systemic amyloidosis is derived from normal transthyretin

Rational design of potent human transthyretin amyloid disease inhibitors

Benzoxazoles as transthyretin amyloid fibril inhibitors: synthesis, evaluation, and mechanism of action

Synthesis and characterization of potent bivalent amyloidosis inhibitors that bind prior to transthyretin tetramerization

Diflunisal analogues stabilize the native state of transthyretin. Potent inhibition of amyloidogenesis

Biochemical and structural evaluation of highly selective 2-arylbenzoxazole-based transthyretin amyloidogenesis inhibitors

Toward Optimization of the Linker Substructure Common to Transthyretin Amyloidogenesis Inhibitors Using Biochemical and Structural Studies †

Toward Optimization of the Second Aryl Substructure Common to Transthyretin Amyloidogenesis Inhibitors Using Biochemical and Structural Studies †

A Substructure Combination Strategy To Create Potent and Selective Transthyretin Kinetic Stabilizers That Prevent Amyloidogenesis and Cytotoxicity

Inhibiting transthyretin conformational changes that lead to amyloid fibril formation

P304

3441-3449

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/J.BMCL.2017.05.080

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Ian Andrew Wilson

Jeffery W. Kelly

P577

2017-05-26T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28625364

http://www.w3.org/2001/XMLSchema#string

P921

drug discovery

Familial amyloid polyneuropathy

Structure-based drug design

pharmaceutical science

P932

5557047

http://www.w3.org/2001/XMLSchema#string